BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 10366135)

  • 1. Determination of nicotine, pH, and moisture content of six U.S. commercial moist snuff products--Florida, January-February 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 May; 48(19):398-401. PubMed ID: 10366135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines.
    Richter P; Hodge K; Stanfill S; Zhang L; Watson C
    Nicotine Tob Res; 2008 Nov; 10(11):1645-52. PubMed ID: 18988077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance of smokeless tobacco nicotine, pH, moisture, and unprotonated nicotine content.
    Richter P; Spierto FW
    Nicotine Tob Res; 2003 Dec; 5(6):885-9. PubMed ID: 14668072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From the Centers for Disease Control and Prevention. Determination of nicotine, pH, and moisture content of six US commercial moist snuff products--Florida, January-February 1999.
    JAMA; 1999 Jun 23-30; 281(24):2279-80. PubMed ID: 10386544
    [No Abstract]   [Full Text] [Related]  

  • 5. Free nicotine content and strategic marketing of moist snuff tobacco products in the United States: 2000-2006.
    Alpert HR; Koh H; Connolly GN
    Tob Control; 2008 Oct; 17(5):332-8. PubMed ID: 18669556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of smokeless tobacco among adults--United States, 1991.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Apr; 42(14):263-6. PubMed ID: 8459796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five leading U.S. commercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines.
    Hoffmann D; Djordjevic MV; Fan J; Zang E; Glynn T; Connolly GN
    J Natl Cancer Inst; 1995 Dec; 87(24):1862-9. PubMed ID: 7494230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of pH and nicotine concentration in oral moist snuff on mucosal changes and salivary pH in Swedish snuff users.
    Andersson G; Warfvinge G
    Swed Dent J; 2003; 27(2):67-75. PubMed ID: 12856395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the nicotine content of smokeless tobacco products.
    Tilashalski K; Rodu B; Mayfield C
    J Am Dent Assoc; 1994 May; 125(5):590-2, 594. PubMed ID: 8195501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic and carcinogenic agents in dry and moist snuff.
    Hoffmann D; Adams JD; Lisk D; Fisenne I; Brunnemann KD
    J Natl Cancer Inst; 1987 Dec; 79(6):1281-6. PubMed ID: 3480379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smokeless tobacco use by youth: a health concern.
    Johnson GK; Squier CA
    Pediatr Dent; 1993; 15(3):169-74. PubMed ID: 8378153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobacco use among middle and high school students--Florida, 1998 and 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Apr; 48(12):248-53. PubMed ID: 10220252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notice regarding requirement for annual submission of the quantity of nicotine contained in smokeless tobacco products manufactured, imported, or packaged in the United States. Centers for Disease Control and Prevention (CDC), Department of Health and Human Services. Notice.
    Fed Regist; 1999 Mar; 64(55):14085-96. PubMed ID: 10558405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical profile of two types of oral snuff tobacco.
    Brunnemann KD; Qi J; Hoffmann D
    Food Chem Toxicol; 2002 Nov; 40(11):1699-703. PubMed ID: 12176096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A qualitative and quantitative risk assessment of snuff dipping.
    Nilsson R
    Regul Toxicol Pharmacol; 1998 Aug; 28(1):1-16. PubMed ID: 9784428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National Institutes of Health consensus statement. Health implications of smokeless tobacco use. NIH Consensus Development Panel.
    Biomed Pharmacother; 1988; 42(2):93-8. PubMed ID: 3048429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accessibility to minors of smokeless tobacco products--Broward County, Florida, March-June 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Dec; 45(49):1079-82. PubMed ID: 8975122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smokeless tobacco usage: a growing and menacing addiction among Hoosier children and young adults.
    Christen AG
    Indiana Med; 1996; 89(2):176-80. PubMed ID: 8867418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversed phase ion-pair liquid chromatographic determination of nicotine in commercial tobacco products. 1. Moist snuff.
    Ciolino LA; McCauley HA; Fraser DB; Barnett DY; Yi TY; Turner JA
    J Agric Food Chem; 1999 Sep; 47(9):3706-12. PubMed ID: 10552709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical and toxicological characteristics of conventional and low-TSNA moist snuff tobacco products.
    Song MA; Marian C; Brasky TM; Reisinger S; Djordjevic M; Shields PG
    Toxicol Lett; 2016 Mar; 245():68-77. PubMed ID: 26802282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.